A citation-based method for searching scientific literature

F Munck, E W Clausen, E Balslev, N Kroman, T F Tvedskov, E V Holm-Rasmussen. Br J Surg 2020
Times Cited: 6







List of co-cited articles
19 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Gary H Lyman, Mark R Somerfield, Linda D Bosserman, Cheryl L Perkins, Donald L Weaver, Armando E Giuliano. J Clin Oncol 2017
200
50

Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?
Ashleigh M Francis, Christine E Haugen, Lynn M Grimes, Jaime R Crow, Min Yi, Elizabeth A Mittendorf, Isabelle Bedrosian, Abigail S Caudle, Gildy V Babiera, Savitri Krishnamurthy,[...]. Ann Surg Oncol 2015
40
33

Risk factors of sentinel and non-sentinel lymph node metastases in patients with ductal carcinoma in situ of the breast: A nationwide study.
Emil Villiam Holm-Rasmussen, Maj-Britt Jensen, Eva Balslev, Niels Kroman, Tove Filtenborg Tvedskov. Breast 2018
10
33

Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019.
H J Burstein, G Curigliano, S Loibl, P Dubsky, M Gnant, P Poortmans, M Colleoni, C Denkert, M Piccart-Gebhart, M Regan,[...]. Ann Oncol 2019
258
33

No more axillary dissection in patients with ductal intraepithelial neoplasia (DIN).
Gabriel Farante, Viviana Galimberti, Stefano Zurrida, Paolo Veronesi, Alberto Luini, Umberto Veronesi. Eur J Cancer 2010
6
33

Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.
Gary H Lyman, Sarah Temin, Stephen B Edge, Lisa A Newman, Roderick R Turner, Donald L Weaver, Al B Benson, Linda D Bosserman, Harold J Burstein, Hiram Cody,[...]. J Clin Oncol 2014
475
33

Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ.
F Magnoni, G Massari, G Santomauro, V Bagnardi, E Pagan, G Peruzzotti, V Galimberti, P Veronesi, V S Sacchini. Br J Surg 2019
13
33

Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years.
Mattia Intra, Nicole Rotmensz, Paolo Veronesi, Marco Colleoni, Simona Iodice, Giovanni Paganelli, Giuseppe Viale, Umberto Veronesi. Ann Surg 2008
85
33

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Armando E Giuliano, Karla V Ballman, Linda McCall, Peter D Beitsch, Meghan B Brennan, Pond R Kelemen, David W Ollila, Nora M Hansen, Pat W Whitworth, Peter W Blumencranz,[...]. JAMA 2017
540
33

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
L M van Roozendaal, B Goorts, M Klinkert, K B M I Keymeulen, B De Vries, L J A Strobbe, C A P Wauters, Y E van Riet, E Degreef, E J T Rutgers,[...]. Breast Cancer Res Treat 2016
38
33

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
F Cardoso, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, I T Rubio, S Zackrisson, E Senkus. Ann Oncol 2019
450
33

Reliability of preoperative breast biopsies showing ductal carcinoma in situ and implications for non-operative treatment: a cohort study.
Gurdeep S Mannu, Emma J Groen, Zhe Wang, Michael Schaapveld, Esther H Lips, Monica Chung, Ires Joore, Flora E van Leeuwen, Hendrik J Teertstra, Gonneke A O Winter-Warnars,[...]. Breast Cancer Res Treat 2019
14
33

Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
Melissa Pilewskie, Michelle Stempel, Hope Rosenfeld, Anne Eaton, Kimberly J Van Zee, Monica Morrow. Ann Surg Oncol 2016
51
33

Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Tina W F Yen, Kelly K Hunt, Merrick I Ross, Nadeem Q Mirza, Gildy V Babiera, Funda Meric-Bernstam, S Eva Singletary, W Fraser Symmans, Sharon H Giordano, Barry W Feig,[...]. J Am Coll Surg 2005
204
33

Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
Chih-Wei Lee, Hwa-Koon Wu, Hung-Wen Lai, Wen-Pei Wu, Shou-Tung Chen, Dar-Ren Chen, Chih-Jung Chen, Shou-Jen Kuo. Eur J Radiol 2016
26
33


Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy.
Yusuke Watanabe, Keisei Anan, Michiyo Saimura, Kenichiro Koga, Minoru Fujino, Mari Mine, Sadafumi Tamiya, Kazuyoshi Nishihara, Toru Nakano, Shoshu Mitsuyama. Breast Cancer 2018
12
33

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
383
33

Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases.
Chiara Trentin, Valeria Dominelli, Patrick Maisonneuve, Simona Menna, Barbara Bazolli, Alberto Luini, Enrico Cassano. Breast 2012
34
33

Cancer statistics, 2015.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2015
16

Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review.
C H M van Deurzen, M G G Hobbelink, R van Hillegersberg, P J van Diest. Eur J Cancer 2007
29
16

Recognition of pathogen-associated molecular patterns by TLR family.
Shizuo Akira, Hiroaki Hemmi. Immunol Lett 2003
801
16

Physical function of the upper limb after breast cancer surgery. Results from the SOUND (Sentinel node vs. Observation after axillary Ultra-souND) trial.
O Gentilini, E Botteri, P Dadda, C Sangalli, C Boccardo, N Peradze, R Ghisini, V Galimberti, P Veronesi, A Luini,[...]. Eur J Surg Oncol 2016
34
16

Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance).
Judy C Boughey, Karla V Ballman, Huong T Le-Petross, Linda M McCall, Elizabeth A Mittendorf, Gretchen M Ahrendt, Lee G Wilke, Bret Taback, Eric C Feliberti, Kelly K Hunt. Ann Surg 2016
214
16


Is Axillary Sentinel Lymph Node Biopsy Required in Patients Who Undergo Primary Breast Surgery?
Toralf Reimer, Jutta Engel, Marcus Schmidt, Birgitte Vrou Offersen, Marjolein L Smidt, Oreste David Gentilini. Breast Care (Basel) 2018
12
16

Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.
Jean-Marc Classe, Cecile Loaec, P Gimbergues, S Alran, C Tunon de Lara, P F Dupre, Roman Rouzier, C Faure, N Paillocher, M P Chauvet,[...]. Breast Cancer Res Treat 2019
61
16

Preoperative axillary ultrasound in breast cancer: safely avoiding frozen section of sentinel lymph nodes in breast-conserving surgery.
Irada Ibrahim-Zada, Clive S Grant, Katrina N Glazebrook, Judy C Boughey. J Am Coll Surg 2013
26
16

Anatomy is not enough: the crucial role of biology and genetics in AJCC eighth edition of the TNM classification for breast cancer.
Francesca Magnoni, Giuseppe Accardo, Elisabetta Rossi, Paolo Veronesi, Giovanni Corso. Ann Transl Med 2019
2
50

Feasibility and surgical impact of Z0011 trial criteria in a single-Institution practice.
Consuelo Morigi, Nickolas Peradze, Viviana Galimberti, Maria Cristina Leonardi, Davide Radice, Giorgia Irene Santomauro, Vincenzo Bagnardi, Mattia Intra, Emma Firpo, Paolo Veronesi. Breast J 2020
5
20


Sentinel lymph node metastasis in microinvasive breast cancer.
Mattia Intra, Stefano Zurrida, Fausto Maffini, Angelica Sonzogni, Giuseppe Trifirò, Roberto Gennari, Paolo Arnone, Guillermo Bassani, Antonio Opazo, Giovanni Paganelli,[...]. Ann Surg Oncol 2003
64
16


Meta-analysis of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initial biopsy-proven node-positive breast cancer.
S R Tee, L A Devane, D Evoy, J Rothwell, J Geraghty, R S Prichard, E W McDermott. Br J Surg 2018
53
16

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Viviana Galimberti, Bernard F Cole, Stefano Zurrida, Giuseppe Viale, Alberto Luini, Paolo Veronesi, Paola Baratella, Camelia Chifu, Manuela Sargenti, Mattia Intra,[...]. Lancet Oncol 2013
691
16

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Viviana Galimberti, Bernard F Cole, Giuseppe Viale, Paolo Veronesi, Elisa Vicini, Mattia Intra, Giovanni Mazzarol, Samuele Massarut, Janez Zgajnar, Mario Taffurelli,[...]. Lancet Oncol 2018
174
16

Role of Sentinel Lymph Node Biopsy in Microinvasive Breast Cancer.
Betty Fan, Jaime A Pardo, Stephanie Serres, Amulya C Alapati, Joanne Szewczyk, Alessandra Mele, Ted A James. Ann Surg Oncol 2020
3
33

Initial results of a novel technique of clipped node localization in breast cancer patients postneoadjuvant chemotherapy: Skin Mark clipped Axillary nodes Removal Technique (SMART trial).
Geok Hoon Lim, Sze Yiun Teo, Mihir Gudi, Ruey Pyng Ng, Jinnie Pang, Yia Swam Tan, Yien Sien Lee, John C Allen, Lester Chee Hao Leong. Cancer Med 2020
5
20

Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatment.
V Galimberti, S K Ribeiro Fontana, P Maisonneuve, F Steccanella, A R Vento, M Intra, P Naninato, P Caldarella, M Iorfida, M Colleoni,[...]. Eur J Surg Oncol 2016
80
16

Axillary treatment for operable primary breast cancer.
Nathan Bromham, Mia Schmidt-Hansen, Margaret Astin, Elise Hasler, Malcolm W Reed. Cochrane Database Syst Rev 2017
39
16

Axillary Management in Breast Cancer Patients: A Comprehensive Review of the Key Trials.
Michael Yan, Mohamed Ahmed Abdi, Conrad Falkson. Clin Breast Cancer 2018
13
16



Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial.
Jana de Boniface, Jan Frisell, Yvette Andersson, Leif Bergkvist, Johan Ahlgren, Lisa Rydén, Roger Olofsson Bagge, Malin Sund, Hemming Johansson, Dan Lundstedt. BMC Cancer 2017
61
16

Evaluating the role of sentinel lymph node biopsy in patients with DCIS treated with breast conserving surgery.
Ted A James, Bryan Palis, Ryan McCabe, Jaime A Pardo, Amulya Alapati, Ogechi Ukandu, Stephanie K Serres, Jennifer Zhang, Alessandra Mele, Matthew Facktor,[...]. Am J Surg 2020
4
25

Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy.
Lynn T Dengel, Kimberly J Van Zee, Tari A King, Michelle Stempel, Hiram S Cody, Mahmoud El-Tamer, Mary L Gemignani, Lisa M Sclafani, Virgilio S Sacchini, Alexandra S Heerdt,[...]. Ann Surg Oncol 2014
78
16

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
Gary H Lyman, Armando E Giuliano, Mark R Somerfield, Al B Benson, Diane C Bodurka, Harold J Burstein, Alistair J Cochran, Hiram S Cody, Stephen B Edge, Sharon Galper,[...]. J Clin Oncol 2005
16

Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study.
Umberto Veronesi, Giuseppe Viale, Giovanni Paganelli, Stefano Zurrida, Alberto Luini, Viviana Galimberti, Paolo Veronesi, Mattia Intra, Patrick Maisonneuve, Francesca Zucca,[...]. Ann Surg 2010
324
16

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
Mila Donker, Geertjan van Tienhoven, Marieke E Straver, Philip Meijnen, Cornelis J H van de Velde, Robert E Mansel, Luigi Cataliotti, A Helen Westenberg, Jean H G Klinkenbijl, Lorenzo Orzalesi,[...]. Lancet Oncol 2014
807
16

Ductal Carcinoma In Situ with Microinvasion on Core Biopsy: Evaluating Tumor Upstaging Rate, Lymph Node Metastasis Rate, and Associated Predictive Variables.
April Phantana-Angkool, Amy E Voci, Yancey E Warren, Chad A Livasy, Lakesha M Beasley, Myra M Robinson, Lejla Hadzikadic-Gusic, Terry Sarantou, Meghan R Forster, Deba Sarma,[...]. Ann Surg Oncol 2019
3
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.